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CLINICAL SCIENCE
Chronic Distal Sensory Polyneuropathy Is a Major
Contributor to Balance Disturbances in Persons
Living With HIV
Duaa Z. Sakabumi, MBBS,a Raeanne C. Moore, PhD,b,c Bin Tang, PhD,d Patrick A. Delaney, MD,c
John R. Keltner, MD, PhD,b,c,d and Ronald J. Ellis, MD, PhDc,e,d
Background: Medical comorbidities accumulate in older persons
living with HIV (PLWH), causing disability and reduced quality of
life. Sensory neuropathy and polypharmacy may contribute to
balance difﬁculties and falls. The contribution of neuropathy
is understudied.
Objective: To evaluate the contribution of chronic distal sensory
polyneuropathy (cDSPN) to balance disturbances among PLWH.
Methods: Ambulatory PLWH and HIV2 adults (N = 3379) were
prospectively studied. All participants underwent a neurologic
examination to document objective abnormality diagnostic of
cDSPN and reported neuropathy symptoms including pain, pares-
thesias, and numbness. Participants provided detailed information
regarding balance disturbance and falls over the previous 10 years.
Balance disturbances were coded as minimal or none and mild-to-
moderate. Covariates included age, HIV disease, and treatment
characteristics and medications (sedatives, opioids,
and antihypertensives).
Results: Eleven percent of participants reported balance disturban-
ces at some time during the last 10 years; the rate in PLWH
participants exceeding that for HIV2 [odds ratio 2.59, 95%
conﬁdence interval: 1.85 to 3.64]. Fifty-two percent met criteria
for cDSPN. Balance problems were more common in those with
cDSPN [odds ratio = 3.3 (2.6–4.3)]. Adjusting for relevant
covariates, balance disturbances attributable to cDSPN were more
frequent among HIV+ than HIV2 (interaction P = 0.001). Among
individuals with cDSPN, older participants were much more likely to
report balance disturbances than younger ones.
Conclusions: cDSPN contributes to balance problems in PLWH.
Assessments of cDSPN in older PLWH should be a clinical priority
to identify those at risk and to aid in fall prevention and the ensuing
consequences, including bone fractures, subdural hematoma, hospi-
tal admissions, and fatal injury.
Key Words: HIV infection, aging, falls, neurology, everyday
functioning
(J Acquir Immune Deﬁc Syndr 2019;80:568–573)
INTRODUCTION
Falls are common among persons living with HIV
(PLWH), particularly in those who are older, affecting 30% of
those older than 50 years in a recent study.1 They may have
a profound impact on quality of life, disability, and health
outcomes.2 For example, balance problems interfere with the
ability to beneﬁt from physical exercise, which is strongly
recommended to reduce cardiovascular risk, and for other
health beneﬁts.3,4 In addition, falls increase the risk of
fractures in PLWH who often have comorbid accelerated
bone mineral density loss.5 Self-reported balance disturbances
represent an important, readily identiﬁable risk factor for
future falls.6 In PLWH, highly prevalent comorbidities and
treatment factors are believed to contribute to balance
disturbances and falls. These include peripheral neuropathy
and polypharmacy.2,3,7
Objective loss of sensory function in the toes and feet
on neurological examination are key features of chronic distal
sensory polyneuropathy (cDSPN). Loss of afferent sensory
signaling from the feet and legs due to neuropathy is a well-
known cause of ataxia, balance disturbances, and falls.
cDSPN is the most common type of peripheral neuropathy
in PLWH, affecting half of those older than 50 years.8
Virologic suppression on antiretroviral therapy does not
eliminate cDSPN,8,9 thus its prevalence remains high,
particularly in older, long-term PLWH survivors.
As yet, no previous study has evaluated how cDSPN,
deﬁned by careful, objective neurological examination,
impacts balance disturbances in PLWH. Previous reports
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have examined neuropathy deﬁned only by the presence of
neuropathic symptoms.1 This is a critical distinction because
more than half of cDSPN in HIV is asymptomatic. We aimed
to evaluate the contribution of cDSPN to balance disturban-
ces, relative to the impact of other comorbidities likely to
affect balance, such as age, polypharmacy, and effectiveness
of antiretroviral therapy. We hypothesized that balance
disturbances would be much more common in PLWH
compared to persons without HIV, and that cDSPN would
be a strong, independent contributor to balance problems.
METHODS
Participants and Design
Participants were ambulatory HIV+ and HIV2 adults
enrolled in NIH-funded research protocols. They were
enrolled at 6 sites (the University of California, San Diego;
the University of Texas, Galveston; Johns Hopkins Univer-
sity; Washington University; the University of Washington
and Mount Sinai) between September 11, 2003, and June 28,
2017. Each participant contributed data from a single baseline
evaluation. The University’s Institutional Review Board
approved this study, and all participants provided written,
informed consent.
Detailed information on the source populations and
methods for these studies has been previously published.8,10
Brieﬂy, data were collected according to a standardized
protocol of comprehensive neuromedical and laboratory
assessments. Eligibility criteria included the ability to
undergo neurologic examination to document objective
abnormalities diagnostic of cDSPN and a structured clinical
interview to provide details of neuropathy symptoms. General
exclusion criteria for the study included blindness, wheelchair
dependence, and falls known to be consequence of sustaining
a violent blow, loss of consciousness, or sudden onset of
paralysis as in stroke or epilepsy.
Clinical Evaluations
Physical Examination and Self-Reported Symptoms
of cDSPN
cDSPN was diagnosed based on a standardized, objec-
tive neurological examination conducted by a trained clini-
cian. cDSPN was deﬁned by the presence of at least one
speciﬁc sign: a consistent pattern of symmetrical, distal,
bilateral reduction in deep tendon reﬂexes or reduced
sensation to pin or vibration. cDSPN symptoms were self-
reported pain (dysesthesia), tingling (paresthesia), and numb-
ness (loss of sensation). In addition, gait was observed by the
clinician; participants were asked to walk as briskly as could
be done safely for 10–20 feet, turn, and return to the starting
point, walking normally, on heels, toes, and in a tandem
fashion. The predominant feature of the subject’s gait pattern
was recorded, ranging from normal gait, neuropathic or “foot
slapping” (predominant abnormality is weakness of foot
dorsiﬂexors), “waddling” (weakness of hip girdle muscles),
ataxia (disproportionate difﬁculty with tandem), paraparesis
(weakness with bilateral spasticity, scissoring), hemiparetic
(unilateral weakness and spasticity), orthopedic (eg, knee,
hip, or ankle pain, or limitation in range of motion), or mixed.
Self-Reported Balance Disturbance
A structured clinical interview was administered to
participants by trained interviewers to collect any history of
balance disturbance and its onset (the past few days up to the
previous 10 years). Interexaminer reliability was ensured
through systematic training. Balance disturbances were
classiﬁed as not present; occasionally unsteady, no falls;
frequently unsteady; some near-falls or rare falls; and must
use a cane, walker, or other prop. We recoded balance
disturbance classes into minimal or none (occasionally
unsteady, no falls) and mild-to-moderate (frequently
unsteady, some near-falls, some falls, or must use a cane,
walker, or other prop).
HIV Characteristics and Covariates
The following HIV disease and treatment data were
obtained: estimated duration of HIV infection, nadir
CD4+ lymphocyte counts, AIDS status, and current use of
cART. Laboratory assays included CD4 and viral load. Data
on use of antihypertensive and other medications, including
sedatives and opioids, and body mass index were obtained to
examine as potential covariates.
Statistical Analysis
Associations of polyneuropathy and HIV status with
balance disturbance were analyzed with Fisher exact test.
Conﬁdence intervals (CIs) for point estimates of frequency
were calculated by using the Wilson procedure with a correc-
tion for continuity. Covariates were evaluated with logistic
regression. Multivariable analyses were adjusted for age, sex,
GDS impairment, sedatives, nadir CD4, duration of HIV
infection, viral load, and use of antihypertensive, sedatives,
and/or opioid medications. Statistical analyses were per-
formed using JMP Pro13 and R statistical software
(version 3.4.1).
RESULTS
Demographic and Clinical Characteristics
Participants were 2647 HIV+ and 732 HIV2 adults
with a mean age of 45.5 years (SD = 11 years). PLWH were
on average 1 year older (P = 0.036) and more likely to be men
(P , 0.0001) and African American (P , 0.0001) than
HIV2 participants (Table 1).
Relationship Between cDSPN, Neuropathic
Symptoms, and Balance Disturbance
Overall, 385 participants [11.3%; (95% CI: 10.3 to
12.5)] reported some balance disturbance during the previous
10 years. The proportion that used a walker, cane, or other
prop was 3.4% (2.8–4.1). Balance disturbances were more
common in HIV+ than HIV2 participants (13.0% vs 5.5%,
odds ratio [OR] = 2.59, 95% CI: 1.85 to 3.64). cDSPN was
present in 52% (50.5–53.9) of the participants and was
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symptomatic (pain, paresthesias, or numbness) 41.6% (39.9–
43.3). cDSPN was more frequent among PLWH (59.4%)
compared to those without HIV-1 infection (26.0%; OR =
4.18, 95% CI: 3.48 to 5.02). Adjusting for demographic
differences (age, sex, and race/ethnicity) between PLWH and
HIV2 participants did not substantially alter the ORs [95%
CI] for balance disturbances (2.67 [2.05 to 3.49]) or for
cDSPN (5.36 [4.33 to 6.66]). Table 2 shows demographics
and HIV disease and treatment characteristics according to
the presence of balance disturbance. Individuals experiencing
balance disturbance were signiﬁcantly older and more likely
to be women, had higher BMI, and were more likely to be of
non-Latino white race/ethnicity than those who did not report
balance disturbance. Among HIV+ individuals, those with
balance disturbances had lower CD4 nadir, longer estimated
duration of HIV infection, and increased use of antihyperten-
sives, opioids, and sedatives.
As seen in Table 3, results showed a signiﬁcant increase
in the risk of balance disturbances in participants with
cDSPN. More severe cDSPN conferred a greater risk of
balance difﬁculties: The odds of balance disturbances
increased from mild cDSPN (only 1 abnormal sign; OR =
2.45, 95% CI: 1.82 to 3.28) to moderate cDSPN ($2 signs;
OR = 5.45, 95% CI: 4.11 to 7.11). cDSPN was associated
with both minimal (OR = 1.91, 95% CI: 1.57 to 2.34) and
mild–moderate (OR = 3.08, 95% CI: 2.46 to 3.84) balance
difﬁculties. The onset of the preponderance of the self-
reported balance disturbances was within the past year
(28%) or 1–10 years (58%). Limiting balance disturbances
to those with reported onset in the past year, cDSPN was still
associated with a signiﬁcantly higher frequency of balance
disturbances (51% vs 30%; P = 0.0014). Self-reported
neuropathic symptoms (pain, paresthesia, and loss of sensa-
tion) also were signiﬁcantly associated with balance distur-
bances. ORs for mild–moderate balance disturbance in
persons with relative to without neuropathic symptoms were
1.81 (95% CI: 1.68 to 1.96, pain), 2.23 (95% CI: 2.01 to 2.48,
paresthesia), and 2.04 (95% CI: 1.87 to 2.22, loss
of sensation).
Gait examination by the clinician revealed an abnormal
ataxic pattern in 4.3% (3.6–5.0) of participants, with other
abnormal patterns in 4.4% (3.8–5.2). Clinical ataxia was more
common in those who self-reported balance disturbance
(13.0%), compared with those who did not (3.1%; OR =
4.62 95% CI: 3.26 to 6.57).
The frequencies of current opioid, antihypertensive
medication, and sedative use among PLWH were 14.5%
(13.3–15.7), 7.8% (6.9–8.9), and 11.2% (10.2–12.3), respec-
tively. ORs for mild–moderate balance disturbance in persons
with relative to without medication use were 3.02 (95% CI:
2.37 to 3.85) for opioids, 1.73 (95% CI: 1.23 to 2.42) for
antihypertensives, and 1.82 (95% CI: 1.37 to 2.43) for sed-
atives. Current opioid use was common in individuals with
cDSPN (OR = 2.28, 95% CI: 1.89 to 2.77), particularly those
who reported neuropathic pain (OR = 3.37, 95% CI: 2.77
to 4.09).
cDSPN and History of Balance Disturbance
Among all study participants, those with cDSPN
were 3 times more likely to have reported balance problems
in the preceding 10 years (OR = 3.30, 95% CI: 2.55 to
4.28). After adjusting for HIV serostatus, age and sex, as
well as sedative and antihypertensive and opioid use, the
OR for DSPN remained signiﬁcant (OR = 2.07, 95% CI:
1.57 to 2.73). A sensitivity analysis showed that removing
individuals who used a cane, walker, or other prop did not
substantially alter the ﬁndings (OR = 2.86, 95% CI: 2.16 to
3.78). Participants with symptomatic cDSPN (1 or more
symptoms) were nonsigniﬁcantly more likely than those
with asymptomatic cDSPN to report balance disturbances
(OR = 5.18, 95% CI: 4.07 to 6.59 vs OR = 3.15, 95% CI:
2.09 to 4.74).
Logistic regression models were run to examine
whether HIV serostatus, age, and sex impacted the relation-
ship between cDSPN and balance disturbance. A signiﬁcant
interaction between HIV serostatus and the presence of
cDSPN was observed, such that balance disturbances attribut-
able to cDSPN were more frequent among HIV+ than HIV2
(Fig. 1; interaction P-value = 0.007) after controlling for
relevant covariates [age, HIV disease, and treatment
TABLE 1. Population Characteristics According to HIV Serostatus, Using Welch T-Test for Normally Distributed Continuous
Variables, the Wilcoxon Rank–Sum Test for Non-normal Data, and Fisher Exact for Categorical Variables
Variable HIV+ (n = 2647) HIV2 (n = 732) Effect Size (95% CI) P
Age (yr), mean (SD) 45.8 (10.5) 44.8 (13.9) 0.09 (0 to 0.17)* 0.038
Education (yr), mean (SD) 12.9 (3.26) 13.6 (4.08) 20.19 (20.27 to 20.11)* ,0.001
Male, n (%) 2147 (81.1) 484 (66.1) 2.2 (1.83 to 2.65)† ,0.001
Ethnicity, n (%) ,0.001
Non-Latino white 1215 (45.9) 410 (56.0)
African American 894 (33.8) 134 (18.3)
Latino 452 (17.1) 143 (19.5)
Other 66 (2.49) 32 (4.37)
Asian 20 (0.76) 13 (1.78)
*Effect size presented as Cohen’s d.
†Effect size presented as odds ratio.
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characteristics and medications (sedatives, opioids,
and antihypertensives)].
The prevalence of balance disturbances in women was
higher than in men (14% vs 10%; P = 0.0045). This was true
regardless of HIV serostatus (for HIV2 women, OR = 2.14,
95% CI: 1.04 to 4.31; for HIV+ women, OR = 1.81, 95% CI:
1.31 to 2.50). The interaction between sex and cDSPN also
was signiﬁcant (Fig. 2; interaction P-value = 0.027) such that
balance disturbances were proportionately more common in
men with cDSPN than in women with cDSPN. Controlling
for relevant covariates did not substantially alter the ﬁndings.
Among all participants, balance disturbances were more
frequent in older vs younger participants [OR 1.42 (1.26 to
1.59) per 10-year increase in age]; the interaction term was
not signiﬁcant (P = 0.77). Results were similar for the
HIV+ subgroup.
DISCUSSION
We found that PLWH as compared with HIV-
uninfected individuals were 3 times more likely to report
balance difﬁculties and 4 times more likely to have cDSPN.
The prevalence of cDSPN in our cohort was high;
similarly, high prevalence has been reported in other
studies.13 PLWH were particularly susceptible to balance
problems attributable to cDSPN. Our ﬁndings were robust
to consideration of covariates including demographics and
polypharmacy. Despite the importance and high prevalence
of neuropathy and its known causal connection to balance
disturbances in conditions other than HIV, this link in
PLWH is understudied.
A major strength of our study is that we assessed the
association of cDSPN with HIV disease in a large, pro-
spectively assembled sample in which all participants under-
went a standardized objective examination for
TABLE 2. Population Characteristics According to Presence or Absence of Balance Disturbance, Using Welch T-Test for Normally
Distributed Continuous Variables, the Wilcoxon Rank–Sum Test for Non-normal Data, and Fisher Exact for Categorical Variables
Variable
Mild–Moderate Balance
Disturbance (n = 385)
Minimal or No Balance
Disturbance (n = 2994) Effect Size (95% CI) P
Demographics
Age (yr), mean (SD) 51.9 (10.6) 44.7 (11.2) 0.68 (0.57 to 0.78)‡ ,0.001
Education (yr), mean (SD) 13.1 (2.98) 13.1 (3.52) 0 (20.11 to 0.11)‡ 0.99
Male, n (%) 278 (72.2%) 2353 (78.6%) 0.71 (0.55 to 0.91)§ 0.006
Ethnicity, n (%) 0.006
Non-Latino White 197 (51.2%) 1428 (47.7%)
African American 127 (33.0%) 901 (30.1%)
Latino 47 (12.2%) 548 (18.3%)
Other 10 (2.60%) 88 (2.94%)
Asian 4 (1.04%) 29 (0.97%)
BMI, mean (SD)* 28.0 (7.15) 26.9 (9.69) 0.16 (0.05 to 0.27)‡ 0.004
HIV disease and treatment characteristics
HIV status, n (%) 345 (89.6%) 2302 (76.9%) 2.59 (1.84 to 3.73)§ ,0.001
AIDS status, n (%) 254 (73.6%) 1399 (60.8%) 1.8 (1.39 to 2.35)§ ,0.001
CD4 current (cells/uL), median (IQR)† 490 (282, 706) 471 (302, 687) 0 (20.11 to 0.12)‡ 0.95
CD4 nadir (cells/uL), median (IQR)† 116 (23, 245) 172 (41, 300) 20.21 (20.32 to 20.09)‡ ,0.001
Plasma viral load undetectable, n (%) 177 (58.2%) 1252 (58.8%) 1.02 (0.79 to 1.31)§ 0.85
cART (currently using), n (%) 292 (84.9%) 1840 (80.0%) 1.4 (1.02 to 1.95)§ 0.034
Duration of infection (yr), mean (SD) 14.5 (13.6) 11.5 (11.0) 0.23 (0.11 to 0.34)‡ ,0.001
Other medication use (n, %)
Antihypertensives (currently using),
n (%)
33 (9.57%) 169 (7.34%) 1.33 (0.87 to 1.99)§ 0.16
Sedatives (currently using), n (%) 58 (16.8%) 280 (12.2%) 1.46 (1.05 to 2)§ 0.019
Opiates (currently using), n (%) 107 (31.0%) 331 (14.4%) 2.68 (2.05 to 3.48)§ ,0.001
*log10 transformed prior to analysis.
†Square root transformed before analysis.
‡Effect size presented as Cohen’s d.
§Effect size presented as odds ratio.
TABLE 3. Odds Ratio for Mild-To-Moderate Balance
Disturbance in Persons With Relative to Without cDSPN Signs
and Symptoms, Using Fisher Exact Test
cDSPN Signs OR 95% CI
$ 2 signs 5.45 4.11 to 7.11
1 sign 2.45 1.82 to 3.28
cDSPN symptoms
Pain 1.81 1.68 to 196
Paresthesia 2.23 2.01 to 2.48
Loss of sensation 2.04 1.87 to 2.22
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polyneuropathy. Participants were derived from multiple
studies with sites across the United States, enhancing
representativeness. The large sample size provided sufﬁcient
power to adjust for multiple comorbidities.
We found that self-reported balance disturbances were
associated with a higher frequency of gait ataxia on objective
clinical examination. However, only a small proportion of
PLWH reporting balance disturbances had frank gait ataxia
on gait examination. Although other interpretations are
possible, we favor the view that the clinical examination is
relatively insensitive to balance disturbances and is particu-
larly likely to miss difﬁculties that are intermittent or subtle.
Both objective ataxia on neurological examination and self-
reported balance disturbances11 are predictive of falls.
Previous research1 found that the odds of falling
increased by 1.7 for PLWH with neuropathy, whereas in
our study, the odds of balance disturbances increased by 3 for
individuals with cDSPN. Several methodological factors may
account for the differences between the 2 studies. We
assessed the presence of polyneuropathy using a previously
validated objective neurological examination, while the pre-
vious study used subjective participant reports of neuropathy
symptoms. We considered a prospectively collected 10-year
history of falls and imbalance, whereas the aforementioned
study assessed only recent fall history (past 12 months).
Another difference between our study and previous work is
the focus on sensory neuropathy. By comparison, Gewandter
et al12 showed that in cancer survivors with chemotherapy-
induced peripheral neuropathy, falls were signiﬁcantly asso-
ciated with motor neuropathy.
Previous research1,2,6,7 found signiﬁcant risk factors for
falls in HIV included female sex, diabetes, antidepressants,
sedatives, opioids, didanosine use, exhaustion, weight loss, and
balance problems (all OR$ 2.5; P# 0.05). We similarly found
that balance disturbances were more common in women than
men and in participants taking sedatives, opioids, and anti-
hypertensives compared with those not on these medications.
Our study has several limitations. The deﬁnition of
balance disturbances included individuals who used a cane,
walker, or other prop. Some of these may have used a prop
due to orthopedic reasons such as hip or knee pathology,
rather than balance difﬁculties. However, the proportion using
a prop was relatively small, and in a sensitivity analysis,
removing these individuals did not substantially alter the
ﬁndings. Participants had to be able to visit the research
center, implying that they were relatively healthy. Under-
representation of less healthy individuals may have resulted in
an underestimation of the impact of cDSPN on balance
disturbances.9 To assess whether the relationship between
cDSPN and balance disturbances might be causal, it would be
helpful to know their temporal ordering, speciﬁcally, whether
cDSPN preceded balance disturbances. In this cross-sectional
study, it was not possible to assess temporal ordering because
the balance disturbances were reported retrospectively,
whereas cDSPN was ascertained prospectively. Patient-
reported symptoms cannot be used to estimate the date of
onset of cDSPN because the condition is asymptomatic in
more than 50% of cases. Nevertheless, we believe that
cDSPN likely preceded and contributed substantially to
balance disturbances for several reasons. First, cDSPN in
HIV is a chronic condition, typically present for many years
before it is evaluated. It is reasonable to expect that cDSPN
was present for some months or years before the clinical
examination performed in this study. Furthermore, the
potential causal connection between loss of afferent sensory
function in cDSPN and balance disturbances is plausible and
has been demonstrated in other patient populations.
We observed a relatively high prevalence of cDSPN in
our HIV2 cohort, suggesting that the cohort may not be
representative of the general population. We believe this
relatively high prevalence is likely due to the fact that HIV2
participants were selected to have risk factors similar to the
HIV+ sample, such as histories of alcohol abuse (27%) and
IV drug use, some of which may inﬂuence the prevalence of
FIGURE 2.
FIGURE 1.
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neuropathy. They also had comorbidities such as diabetes
mellitus (7%), a risk factor for neuropathy, and overweight/
obesity. A limitation of many previous studies of HIV2
individuals is that they deﬁned neuropathy on the basis of
symptoms alone, rather than clinical examination. This
approach is likely to produce substantial underestimates of
prevalence because cDSPN is frequently asymptomatic.
Some previous studies have found HIV2 individuals to have
a prevalence of cDSPN similar to that found in our report. For
example, the prevalence of peripheral neuropathy was 29%
among subjects at risk for diabetes mellitus with an average
age of 53 years14
Because of the cross-sectional design of our study, we
were not able to investigate causal relationships between
polyneuropathy and HIV disease. However, the causal
relationship is intuitively plausible and supported by previous
research, and it survived evaluation of important covariates.
In our study, we associated cDSPN with HIV disease. These
associations were independent of age, sex, and diabetes
mellitus. Factors not directly assessed in this study may
contribute to balance disturbance. However, we excluded data
from participants affected by many of these conditions,
including blindness, and balance disturbances known to be
consequence of sustaining a violent blow, loss of conscious-
ness, or sudden onset of paralysis as in stroke or epilepsy.
Other conditions such as knee or hip arthritis and vestibular
disorders are often associated with balance disturbance. These
conditions may, in turn, be more common among those with
cDSPN, confounding the association with it.
In conclusion, chronic polyneuropathy is a disabling
disorder that causes signiﬁcant disability by itself10 and leads
to additional morbidity by exacerbating fall risk. cDSPN is
frequently asymptomatic, meaning that recognition requires
neurological examination.8 The examination for cDSPN
requires 2–3 minutes and substantially enhances the detec-
tion of those at risk for falls. Previous studies have demon-
strated that physical therapy and physical exercise,
particularly gait training, are effective in preventing future
falls.3,4 An important issue for future studies to address is
whether objective evidence of cDSPN and self-reported
balance disturbances predict preventable falls in PLWH
prospectively followed.
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